Esticast Logo
Get In Touch!

Parathyroid Hormone Analog Market By Product Type ( Abaloparatide, Teriparatide, Human Parathyroid Hormone Recombinant ), By Application ( Hospitals, Clinics ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 164
Parathyroid Hormone Analog Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Parathyroid hormone, also called as (PTH) analogue is a synthetic form of naturally occurring parathyroid hormone, which is used as a medication therapy in order to increase bone strength, propelling the formation of bone mass. Parathyroid hormone analogs extensively control the proper distribution of elements such as phosphate and calcium in the human body. People having reduced amount of parathyroid hormone can severely suffer reduced amount of calcium in the bones, which might generate diseases such as Osteoprosis. Osteoprosis is a condition when the bones become fragile and get brittle in nature. Recombinant human parathyroid hormone (PTH) analogues and teriparatides are the most adopted medication therapies for this medical condition as these analogs increase the possibility of increasing the formation of new bone substance because of anabolic effects presented by them. PTH analogs not only provides bone strength but also improves the microarchitecture of the complete skeleton. However, the need for daily self-injection and the extremely high cost of the treatment might act as a major restraining factor for the very market. As per the statistics revealed by the International Osteoporosis foundation, Osteoporosis causes more than 8.9 million fractures annually, all over the world, resulting in an osteoporotic fracture every 3 seconds. By 2050, the worldwide incidence of hip fracture in men is estimated to escalate by 310% and 240% in women, compared to rates in 1990. This clearly depicts that the market is yet to experience a bright growth in the upcoming future. The report provides detailed qualitative and quantitative analysis of the Parathyroid Hormone Analog Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Parathyroid Hormone Analog Market Segmentation

By Product Type • Abaloparatide • Teriparatide • Human Parathyroid Hormone Recombinant By Application • Hospitals • Clinics • Other By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources

CHAPTER 2. PARATHYROID HORMONE ANALOG MARKET OVERVIEW
2.1. PARATHYROID HORMONE ANALOG MARKET INTRODUCTION
2.2. GLOBAL PARATHYROID HORMONE ANALOG MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. Global Parathyroid Hormone Analog Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3. GLOBAL PARATHYROID HORMONE ANALOG MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. Global Parathyroid Hormone Analog Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4. GLOBAL PARATHYROID HORMONE ANALOG MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. Global Parathyroid Hormone Analog Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5. GLOBAL PARATHYROID HORMONE ANALOG MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. Global Parathyroid Hormone Analog Consumption (VOLUME) and Growth Rate (%), (2017-2025)
2.6. GLOBAL PARATHYROID HORMONE ANALOG MARKET PRICE TREND, 2017-2025
2.6.1. Global Parathyroid Hormone Analog Market Price Trend and Growth Rate (%), (2017-2025)

CHAPTER 3. GLOBAL PARATHYROID HORMONE ANALOG MARKET BY TYPE, 2017-2025
3.1. ABALOPARATIDE
3.2. TERIPARATIDE
3.3. HUMAN PARATHYROID HORMONE RECOMBINANT
3.4. GLOBAL PARATHYROID HORMONE ANALOG MARKET REVENUE BY TYPE, 2017-2025
3.4.1. Global Parathyroid Hormone Analog Market Revenue (Million USD) and Share (%) By Type, 2017-2025
3.4.2. Abaloparatide Market Revenue and Growth Rate, 2017-2025
3.4.3. Teriparatide Market Revenue and Growth Rate, 2017-2025
3.4.4. Human Parathyroid Hormone Recombinant Market Revenue and Growth Rate, 2017-2025
3.5. GLOBAL PARATHYROID HORMONE ANALOG MARKET PRODUCTION BY TYPE, 2017-2025
3.5.1. Global Parathyroid Hormone Analog Market Production (Volume) and Share (%) By Type, 2017-2025
3.5.2. Abaloparatide Market Production and Growth Rate, 2017-2025
3.5.3. Teriparatide Market Production and Growth Rate, 2017-2025
3.5.4. Human Parathyroid Hormone Recombinant Market Production and Growth Rate, 2017-2025

CHAPTER 4. GLOBAL PARATHYROID HORMONE ANALOG MARKET BY APPLICATION, 2017-2025
4.1. HOSPITALS
4.2. CLINICS
4.3. OTHER
4.4. GLOBAL PARATHYROID HORMONE ANALOG MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1. Global Parathyroid Hormone Analog Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.4.2. Hospitals Market Revenue and Growth Rate, 2017-2025
4.4.3. Clinics Market Revenue and Growth Rate, 2017-2025
4.4.4. Other Market Revenue and Growth Rate, 2017-2025
4.5. GLOBAL PARATHYROID HORMONE ANALOG MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.5.1. Global Parathyroid Hormone Analog Market Consumption (Volume) and share (%) By Application, 2017-2025
4.5.2. Hospitals Market Consumption and Growth Rate, 2017-2025
4.5.3. Clinics Market Consumption and Growth Rate, 2017-2025
4.5.4. Other Market Consumption and Growth Rate, 2017-2025

CHAPTER 5. GLOBAL PARATHYROID HORMONE ANALOG MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. Canada
5.1.3. Mexico
5.2. EUROPE
5.2.1. U.K.
5.2.2. France
5.2.3. Germany
5.2.4. Italy
5.2.5. Spain
5.2.6. Rest of Europe
5.3. ASIA PACIFIC
5.3.1. China
5.3.2. Japan
5.3.3. India
5.3.4. Korea
5.3.5. Rest of APAC
5.4. SOUTH AMERICA
5.4.1. Brazil
5.4.2. Rest of South America
5.5. REST OF THE WORLD
5.5.1. Middle East
5.5.2. Africa
5.6. GLOBAL PARATHYROID HORMONE ANALOG MARKET REVENUE BY REGION, 2017-2025
5.6.1. Global Parathyroid Hormone Analog Market Revenue (Million USD) and Share (%) By Region, 2017-2025
5.6.2. North America Market Revenue and Growth Rate, 2017-2025
5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
5.6.5. South America Market Revenue and Growth Rate, 2017-2025
5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 6. GLOBAL PARATHYROID HORMONE ANALOG MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL PARATHYROID HORMONE ANALOG MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
6.1.1. Global Parathyroid Hormone Analog Market Production (Volume) and Share (%) By Region, 2017-2025
6.1.2. Global Parathyroid Hormone Analog Market Consumption (Volume) and Share (%) By Region, 2017-2025
6.1.3. North America Market Production and Consumption, 2017-2025
6.1.4. Europe Market Production and Consumption, 2017-2025
6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
6.1.6. South America Market Production and Consumption, 2017-2025
6.1.7. Rest of the World Market Production and Consumption, 2017-2025

CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 8. GLOBAL PARATHYROID HORMONE ANALOG MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL PARATHYROID HORMONE ANALOG PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. Global Parathyroid Hormone Analog Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
8.2. GLOBAL PARATHYROID HORMONE ANALOG REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. Global Parathyroid Hormone Analog Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
8.3. PARATHYROID HORMONE ANALOG MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. Parathyroid Hormone Analog Market Share (%) of Top 3 Manufacturers
8.3.2. Parathyroid Hormone Analog Market Share (%) of Top 5 Manufacturers

CHAPTER 9. GLOBAL PARATHYROID HORMONE ANALOG MANUFACTURERS ANALYSIS
9.1. PFIZER
9.1.1. Business Overview
9.1.2. Company Basic Information
9.1.3. Parathyroid Hormone Analog Product Details
9.1.4. Pfizer Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.2. ABBOTT LABORATORIES
9.2.1. Business Overview
9.2.2. Company Basic Information
9.2.3. Parathyroid Hormone Analog Product Details
9.2.4. Abbott Laboratories Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.3. MERCK
9.3.1. Business Overview
9.3.2. Company Basic Information
9.3.3. Parathyroid Hormone Analog Product Details
9.3.4. Merck Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.4. NATPARA
9.4.1. Business Overview
9.4.2. Company Basic Information
9.4.3. Parathyroid Hormone Analog Product Details
9.4.4. Natpara Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.5. GLAXOSMITHKLINE PLC
9.5.1. Business Overview
9.5.2. Company Basic Information
9.5.3. Parathyroid Hormone Analog Product Details
9.5.4. Glaxosmithkline Plc Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.6. SANOFI SA
9.6.1. Business Overview
9.6.2. Company Basic Information
9.6.3. Parathyroid Hormone Analog Product Details
9.6.4. Sanofi Sa Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.7. ELI LILLY
9.7.1. Business Overview
9.7.2. Company Basic Information
9.7.3. Parathyroid Hormone Analog Product Details
9.7.4. Eli Lilly Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.8. CELL GENESYS INC
9.8.1. Business Overview
9.8.2. Company Basic Information
9.8.3. Parathyroid Hormone Analog Product Details
9.8.4. Cell Genesys Inc Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.9. OSI PHARMACEUTICALS
9.9.1. Business Overview
9.9.2. Company Basic Information
9.9.3. Parathyroid Hormone Analog Product Details
9.9.4. Osi Pharmaceuticals Parathyroid Hormone Analog Production, Revenue and Gross Margin
9.10. PALADIN LABS INC.
9.10.1. Business Overview
9.10.2. Company Basic Information
9.10.3. Parathyroid Hormone Analog Product Details
9.10.4. Paladin Labs Inc. Parathyroid Hormone Analog Production, Revenue and Gross Margin

CHAPTER 10. PARATHYROID HORMONE ANALOG MARKET VALUE CHAIN ANALYSIS
10.1. PARATHYROID HORMONE ANALOG INDUSTRIAL CHAIN ANALYSIS
10.2. PARATHYROID HORMONE ANALOG KEY RAW MATERIALS ANALYSIS
10.2.1. Key Raw Materials
10.2.2. Price Trend of Key Raw Materials
10.2.3. Key Suppliers of Raw Materials
10.3. MARKETING CHANNEL
10.3.1. Direct Marketing
10.3.2. Indirect Marketing
10.3.3. Distributors/Traders
10.4. CONSUMER ANALYSIS
10.4.1. Consumer 1
10.4.2. Consumer 2
10.4.3. Consumer 3
10.4.4. Consumer 4

• Pfizer
• Abbott Laboratories
• Merck
• Natpara
• Glaxosmithkline Plc
• Sanofi Sa
• Eli Lilly
• Cell Genesys Inc
• Osi Pharmaceuticals
• Paladin Labs Inc.
• Alza Corporation

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2022 | All Rights Reserved by Esticast Research & Consulting